2021 Aacr Publications Media Kit

2021 AACR PUBLICATIONS MEDIA KIT AACRJournals.org TRUSTED AND TIMELY PUBLICATION OF SCIENTIFIC DISCOVERIES Founded in 1907, the American Association for Cancer Research (AACR) is the first and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research. For over a century, our mission has always been to prevent and cure cancer through research, education, communication, and collaboration. The AACR currently publishes nine peer-reviewed journals that cover the full spectrum of cancer research. In 2020, we added Blood Cancer Discovery, broadening our highly esteemed portfolio’s scope to include all research on hematologic malignancies. The AACR Journals’ reputation for scientific breadth and excellence continues to attract the premier researchers in the field. We are proud to note that four of the AACR journals rank in the top 25 of all oncology journals in terms of Impact Factor, and while AACR publishes around 4.5% of the articles in the Oncology category, our journals garnered 14% of all citations in the field in 2019, according to Clarivate Analytics’ 2019 Journal Citation Reports® (Clarivate Analytics 2020). Cancer Discovery received an Impact Factor of 29.497 and ranks 6th overall in the Oncology category, while Clinical Cancer Research, Cancer Research, and Cancer Immunology Research rank 17th, 19th, and 23rd out of 244 journals in the Oncology category, respectively. For More Information: Maura Paoletti National Sales Manager The Walchli Tauber Group 443-512-8899 ext. 110 [email protected] AACRJournals.org CANCER RESEARCH The Foundational Cancer Journal Driving Transformative Science Commitment and Issue Date Material Deadline 1/1/21 11/25 As one of the most frequently cited and well-respected 1/15/21 12/13 cancer journals in the world, Cancer Research publishes 2/1/21 1/2 original studies, reviews, and opinion pieces offering 2/15/21 1/15 significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and 3/1/21 2/1 epidemiologic research. Cancer Research seeks manuscripts 3/15/21 2/11 that offer pathobiological and translational impact to 4/1/21* 3/4 inform the personal, clinical, and societal problems posed 4/15/21 3/14 by cancer. The main scope of the Journal is captured in its 5/1/21 4/3 primary subsections, which focus on molecular and cellular 5/15/21 4/15 pathobiology, tumor and stem cell biology, therapeutics and 6/1/21 5/7 targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology. 6/15/21 5/15 7/1/21 6/4 Impact Factor: 9.727 (2019) 7/15/21 6/17 Frequency: Semi-monthly print issues 8/1/21 7/7 8/15/21 7/15 First Published: 1941 9/1/21 8/1 Peer Reviewed: Yes 9/15/21 8/15 10/1/21 9/4 Editor-in-Chief: Chi Van Dang, MD, PhD, 10/15/21 9/16 Ludwig Institute for Cancer Research (New York, NY) 11/1/21 10/2 11/15/21 10/15 12/1/21 11/1 12/15/21 11/14 *Annual Meeting Issue Cancer Research Rates Print Advertising Digital Advertising Frequency 1x Multiple Website Statistics ETOCs Full Page $1,885 $1,710 96,000 users/month 12,000 recipients/2X per month 1/2 Page $1,200 $1,100 710,000 page views/month $1,800 net per deployment 1/4 Page $875 $775 140,000 sessions/month Discount offered with multiple deployments 4-Color Rates: $700 Banner Ads (in addition to B/W rates) 310,000 US impressions/month Global $45.00 CPM Premium Opportunities: USA Only $50.00 CPM C2: +25% C3: +10% C4: +50% Guaranteed Position: +15% cancerres.AACRJournals.org CLINICAL CANCER RESEARCH The Journal of Clinical and Translational Research Commitment and Issue Date Material Deadline 1/1/21 12/5 Clinical Cancer Research focuses on innovative clinical 1/15/21 12/18 and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested 2/1/21 1/2 in clinical trials evaluating new treatments, accompanied 2/15/21 1/15 by research on pharmacology and molecular alterations or 3/1/21 1/31 biomarkers that predict response or resistance to treatment. 3/15/21 2/10 The Journal also prioritizes laboratory and animal studies 4/1/21* 2/27 of new drugs and molecule-targeted agents with the 4/15/21 3/10 potential to lead to clinical trials and studies of targetable 5/1/21 3/25 mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. 5/15/21 4/9 6/1/21 4/24 Impact Factor: 10.107 (2019) 6/15/21 5/5 Frequency: Semi-monthly print issues 7/1/21 5/29 7/15/21 6/13 First Published: 1995 8/1/21 6/28 Peer Reviewed: Yes 8/15/21 7/14 9/1/21 7/29 Editor-in-Chief: Keith T. Flaherty, MD, Henri and Belinda 9/15/21 8/15 Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center (Boston, MA) 10/1/21 8/30 10/15/21 9/15 11/1/21 9/30 11/15/21 10/14 12/1/21 10/30 12/15/21 11/14 *Annual Meeting Issue Clinical Cancer Research Rates Print Advertising Digital Advertising Frequency 1x Multiple Website Statistics ETOCs Full Page $1,125 $1,025 31,000 users/month 9,500 recipients/2X per month 1/2 Page $750 $650 505,000 page views/month $1,800 net per deployment 1/4 Page $525 $425 104,000 sessions/month Discount offered with multiple deployments 4-Color Rates: $700 Banner Ads (in addition to B/W rates) 222,000 US impressions/month Global $45.00 CPM Premium Opportunities: USA Only $50.00 CPM C2: +25% C3: +10% C4: +50% Guaranteed Position: +15% clincancerres.AACRJournals.org CANCER DISCOVERY The Essential Information Source to Serve the Diverse Professional Community in Cancer Science and Medicine Commitment and Issue Date Material Deadline 1/1/21 12/5 Cancer Discovery publishes paradigm-changing, 2/1/21 1/2 peer-reviewed articles describing major advances in research and clinical trials. Cancer Discovery also publishes 3/1/21 2/1 review articles, perspectives and commentaries, news, and 4/1/21* 3/6 Research Watch summaries of important journal articles. 5/1/21 4/3 Topics span the spectrum of cancer research and medicine, 6/1/21 5/1 from the laboratory to the clinic to epidemiologic studies. 7/1/21 6/2 Impact Factor: 29.497 (2019) 8/1/21 7/1 9/1/21 8/1 Monthly print issues Frequency: 10/1/21 8/29 First Published: 2011 11/1/21 9/30 12/1/21 10/30 Peer Reviewed: Yes *Annual Meeting and Editors-in-Chief: Lewis C. Cantley, PhD, Weill Cornell Medical 10th Anniversary Issue - Rates Vary College and NewYork-Presbyterian Hospital (New York, NY) Greatest Hits issue planned for Luis A. Diaz, MD, Memorial Sloan Kettering Cancer Center Fall 2021 release. - Please (New York, NY) inquire for rates. Cancer Discovery Rates Print Advertising Digital Advertising Frequency 1x Multiple Website Statistics ETOCs Full Page $1,125 $1,025 36,000 users/month 15,200 recipients per month 1/2 Page $750 $650 227,000 page views/month $1,800 net per deployment 1/4 Page $525 $425 52,000 sessions/month Discount offered with multiple deployments 4-Color Rates: $700 Banner Ads (in addition to B/W rates) 128,000 US impressions/month Global $45.00 CPM Premium Opportunities: USA Only $50.00 CPM C2: +25% C3: +10% C4: +50% Guaranteed Position: +15% 10th Anniversary Issues - please contact [email protected] for rates cancerdiscovery.AACRJournals.org MOLECULAR CANCER THERAPEUTICS The Journal of Cancer Drug Discovery and Preclinical Development Commitment and Issue Date Material Deadline 1/1/21 12/4 Molecular Cancer Therapeutics focuses on basic research 2/1/21 1/8 that has implications for cancer therapeutics in the following areas: experimental cancer therapeutics, 3/1/21 2/5 identification of molecular targets, targets for 4/1/21* 3/3 chemoprevention, new models, cancer chemistry and 5/1/21 4/1 drug discovery, molecular and cellular pharmacology, 6/1/21 5/1 molecular classification of tumors, and bioinformatics and 7/1/21 6/4 computational molecular biology. 8/1/21 7/1 Impact Factor: 5.615 (2019) 9/1/21 8/2 10/1/21 9/7 Frequency: Monthly print issues 11/1/21 10/3 First Published: 2001 12/1/21 11/1 *Annual Meeting Issue Peer Reviewed: Yes Editor-in-Chief: Beverly A. Teicher, PhD (Rockville, MD) Molecular Cancer Therapeutics Rates Print Advertising Digital Advertising Frequency 1x Multiple Website Statistics ETOCs Full Page $855 $755 22,000 users/month 6,100 recipients per month 1/2 Page $585 $485 130,000 page views/month $1,800 net per deployment 1/4 Page $450 $350 30,000 sessions/month Discount offered with multiple deployments 4-Color Rates: $700 Banner Ads (in addition to B/W rates) 60,000 US impressions/month Global $45.00 CPM Premium Opportunities: USA Only $50.00 CPM C2: +25% C3: +10% C4: +50% Guaranteed Position: +15% mct.AACRJournals.org CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION Translating Science to Populations Commitment and Cancer Epidemiology, Biomarkers & Prevention publishes original Issue Date Material Deadline peer-reviewed, population-based research on cancer etiology, 1/1/21 12/9 prevention, surveillance, and survivorship. The following topics are of 2/1/21 1/9 special interest: descriptive, analytical, and molecular epidemiology; 3/1/21 2/7 biomarkers, including assay development, validation, and application; 4/1/21* 3/7 chemoprevention and other types of prevention research in 5/1/21 4/3 the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship 6/1/21 5/1 studies; and risk factors and the science of cancer health disparities.

Load more